Provided by Tiger Trade Technology Pte. Ltd.

Lantheus

100.77
+0.30000.30%
Volume:1.14M
Turnover:115.03M
Market Cap:6.56B
PE:24.22
High:100.91
Open:100.71
Low:100.38
Close:100.47
52wk High:111.86
52wk Low:49.67
Shares:65.10M
Float Shares:58.53M
Volume Ratio:0.97
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.16
EPS(LYR):3.41
ROE:22.21%
ROA:8.38%
PB:5.00
PE(LYR):29.55

Loading ...

B. Riley Adjusts Price Target on Lantheus Holdings to $129 From $97, Maintains Buy Rating

MT Newswires Live
·
Jul 09

Lantheus Holdings Inc : B. Riley Raises Target Price to $129 from $97

THOMSON REUTERS
·
Jul 09

Did FDA’s Facility-Related LNTH-2501 Delay and Russell Additions Just Reframe Lantheus Holdings’ (LNTH) Risk Profile?

Simply Wall St.
·
Jul 03

Lantheus Holdings Price Target Maintained with a $115.00/share by Citizens

Dow Jones
·
Jun 29

Street View: Lantheus' Tumor Kit Setback Seen as Temporary, with Growth Catalysts Still Ahead

Reuters
·
Jun 29

Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday

Benzinga Earnings
·
Jun 29

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Lantheus (LNTH)

TIPRANKS
·
Jun 27

US FDA Declines to Approve Lantheus’ Tumor Imaging Kit

Reuters
·
Jun 27

Lantheus Says FDA Issues CRL for Lnth-2501 over Third-party Manufacturing Conditions

Reuters
·
Jun 27

Lantheus Holdings - FDA Cannot Approve Lnth-2501 Nda by June 29, 2026 Due to Manufacturing Conditions

THOMSON REUTERS
·
Jun 27

Lantheus Holdings - Lnth-2501 Nda Approval Requires Resolution of Facility Inspection Conditions

THOMSON REUTERS
·
Jun 27

Lantheus Holdings - Crl Does not Identify Data, Safety, or Efficacy Concerns for Lnth-2501

THOMSON REUTERS
·
Jun 27

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

GlobeNewswire
·
Jun 27

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH), GoodRx Holdings (GDRX) and Claritev (CTEV)

TIPRANKS
·
Jun 23

Lantheus (LNTH) Gets a Sell from Baptista Research

TIPRANKS
·
Jun 18

Lantheus (LNTH) Stock And The Valuation Implications Of Its Award-Winning Imaging Agent

Simply Wall St.
·
Jun 16

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 04

Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year

GlobeNewswire
·
Jun 02

Assessing Lantheus Holdings (LNTH) Valuation As New ASCO 2026 Oncology Data Nears Publication

Simply Wall St.
·
May 31

Lantheus price target raised to $115 from $100 at Mizuho

TIPRANKS
·
May 27